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Reconstruction of the branches of the aortic
arch, the supra-aortic trunks (SATs), can in most
cases be performed with either a transthoracic or a
cervical approach. The transthoracic approach car-
ries a higher patient morbidity rate. However, the
approach may provide more durable results when
atherosclerotic disease involves the innominate
artery, particularly when it is associated with disease
in the left common carotid or the left subclavian
arteries. The cervical approach is less morbid and is
ideally suited for single-trunk disease that involves
the subclavian or common carotid arteries.
Patients with severe cardiopulmonary restriction
or those who have had previous mediastinal surgery
are also poor candidates for a transthoracic opera-
tion. These patients should undergo reconstruction
with cervical techniques, even in cases of multiple
trunk involvement, as long as there is a suitable cer-
vical donor artery.
Cervical reconstruction of the SAT has evolved
over the years as we have added technical variations
to our protocols to improve our results. Since the
beginning of this series, we have preferred prosthet-
ic material to autogenous conduits, we have gradu-
ally relegated bypass grafting in favor of transposi-
tion as a method of reconstruction, and we have
advocated the retropharyngeal route to cross the
midline rather than the conventional pretracheal
route.
In this review, we analyze the long-term results
of the various techniques used for the cervical recon-
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Purpose: The purpose of this study was to review 182 consecutive cervical reconstruc-
tions of supra-aortic trunks, which were performed over a 16-year period. 
Methods: A total of 182 innominate, common carotid, or subclavian arteries were recon-
structed with a cervical approach in 173 patients aged 23 days to 83 years. Indications
included hemispheric (n = 79), vertebrobasilar (n = 56), upper extremity (24), and inter-
nal mammary/cardiac ischemia (n = 5), asymptomatic severe common carotid disease (n
= 33), or other (n = 3). Primary atherosclerotic innominate (n = 6), common carotid (n
= 84), and subclavian (n = 66) lesions underwent reconstruction. Thirty-one operations
were performed for multiple trunk involvement, recurrent disease, arteritis, infection,
dissection, coarctation, or aneurysm. There were 122 bypass grafting procedures (98
ipsilateral, 24 contralateral) and 60 arterial transpositions. 
Results: One death (0.5%) and 7 nonfatal strokes (3.8%) occurred, none in patients who
were asymptomatic. Perioperative morbidity included four asymptomatic occlusions
(2%), 6 myocardial infarctions (3%), 10 pulmonary complications (5%), and 2 graft
infections (1%). Follow-up periods ranged from 1 to 190 months (mean, 53 ± 5
months). Nineteen patients (10%) were lost to follow-up. Fifty-seven late deaths
occurred, most from cardiac causes. Seven reconstructions necessitated late revision. The
cumulative primary patency rate at 5 and 10 years was 91% ± 2% and 82% ± 5%, respec-
tively. The survival rate at 5 years was 72% ± 4% and at 10 years was 41% ± 6%. The
stroke-free survival rate was 92% ± 2% at 5 years and 84% ± 2% at 10 years.
Conclusion: Cervical reconstruction of symptomatic and asymptomatic supra-aortic
trunk lesions carries acceptable death and stroke rates and provides a long-term patient
benefit. This should be the preferred approach for asymptomatic lesions and for patients
with significant comorbidity because it carries less morbidity than direct transmediasti-
nal aortic-based reconstruction. (J Vasc Surg 1999;29:239-48.)
239
From the Division of Vascular Surgery, Wayne State University/
Detroit Medical Center, Harper Hospital.
Presented at the Forty-sixth Scientific Meeting of the
International Society for Cardiovascular Surgery, North
American Chapter, San Diego, Calif, June 7–8, 1998.
Reprint requests: Ramon Berguer, MD, PhD, Division of
Vascular Surgery, Wayne State University/Detroit Medical
Center, Harper Hospital, 3990 John R, Detroit, MI 48201.
Copyright © 1999 by the Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/99/$8.00 + 0 24/6/93678
struction of the SAT. After following these patients
for an adequate length of time, we have quantified
graft patency, stroke protection, and survival rates.
PATIENTS AND METHODS
Patients. In a 16-year period that extended from
1981 to 1996, 182 cervical reconstructions were
performed to treat symptomatic and asymptomatic
disease that involved the SATs. During this same 16-
year period, we completed another 100 transtho-
racic reconstructions that were the subject of a pre-
vious report.1 Patient medical records were reviewed
in detail, and efforts were made to contact the
patients and to update the reconstruction patency
data and the survival statistics. A large proportion of
the patients who originally were thought to be 
lost to follow-up were tracked via the Internet
(Division for Vital Records and Health Statistics,
www.mdch.state.mi.vs).
The 182 reconstructions were performed in 173
patients. Eighty-three of the patients were male and
90 were female. The mean patient age was 62 ± 10.5
years, and the ages ranged from 23 days to 83 years.
The innominate artery, the prevertebral seg-
ments of the subclavian arteries, and both the com-
mon carotid arteries were considered SATs. Most of
the patients (61%) had single-vessel atherosclerotic
occlusive disease that involved the innominate, prox-
imal common carotid, or subclavian arteries.
Another 22% had more than one trunk that was
stenosed, but only a single vessel underwent recon-
struction. Three patients (2%) in this series under-
went treatment for multiple branch atherosclerosis
with branched prosthetics. The remaining 15% of
the patients in this series underwent treatment for
arteritic occlusive disease (Takayasu’s arteritis, 2;
radiation, 11), restenosis of a previous reconstruc-
tion (8), graft infection (2), arterial dissection (2),
aortic coarctation (2), or aneurysmal degeneration
(1). Thirty patients who underwent common
carotid resection and replacement with autogenous
arterial grafts during cancer operations have been
described elsewhere and are not included in this
report.2
Before surgery, 149 patients (82%) were sympto-
matic from the SAT disease. The patients were seen
with cerebrovascular ischemia (66%), arm claudica-
tion or critical hand ischemia (13%), or left internal
mammary artery (LIMA) steal that lead to recurrent
or persistent angina or congestive heart failure after
LIMA-coronary bypass grafting (3%). Previous
bypass graft infection (n = 2), asymptomatic dissec-
tion (n = 1), and common carotid aneurysm (n = 1)
were additional indications for operative interven-
tion (Table I).
Thirty-three operations (18%) were performed
in patients without symptoms. These patients were
identified during an evaluation for asymptomatic
carotid bifurcation stenosis or after the identification
of blood pressure differentials on routine physical
examination.
Nineteen percent of the patients had previously
undergone a median sternotomy for cardiac surgery,
and 5% of the patients had a prior transthoracic SAT
repair. Other patient comorbidities are listed in
Table II.
Before cervical reconstruction of SAT lesions, 51
patients (28%) had undergone a total of 70 operative
cerebrovascular or proximal upper extremity recon-
structions. Thirty-four patients had undergone cardiac
surgery or an aortic coarctation repair (Table III).
All the operations were preceded by preoperative
arch and four-vessel arteriography. The indications
for arteriographic evaluation most commonly
included cerebrovascular or upper extremity
ischemic symptoms or a duplex scan ultrasound
examination that showed significant disease at the
carotid bifurcation. Cervical or supraclavicular
bruits, radial or temporal pulse deficits, and upper
extremity blood pressure differentials also con-
tributed to the clinical diagnosis of SAT disease and
prompted an arteriographic evaluation.
At angiography, severe disease was defined as a
stenosis of >75% diameter. In patients who were
symptomatic, severe disease was defined as a deep
ulceration within a plaque or the presence of throm-
bus within the arterial lumen.
Fifty patients (27%) had multiple SAT lesions.
Four vessels were diseased in three patients, three
vessels in nine patients, and two in 38 patients. A
single SAT vessel was involved with disease in 130
patients (71%). Fifteen patients had significant dis-
ease in the innominate artery, and 127 and 103
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Table I. Clinical presentation
Presenting symptoms No. of patients
Hemispheric TIA/amaurosis 59 (33%)
Hemispheric stroke 20 (11%)
Vertebrobasilar ischemia 56 (31%)
Arm claudication 8 (4%)
Hand ischemia 16 (9%)
Myocardial ischemia 5 (3%)
Other 4 (2%)
No symptoms 33 (18%)
TIA, Transient ischemic attack.
patients had common carotid or subclavian artery
stenoses or occlusions, respectively. The two patients
who required infected graft removal had no other
SAT that was diseased at the time of the index pro-
cedure.
In addition, arteriogram showed a bovine con-
figuration to the aortic arch in 21 patients (12%) and
an anomalous right subclavian artery that arose from
the aorta beyond the left subclavian artery in two
patients (1%). The innominate artery was shown by
means of angiography to be occluded or ligated in
eight patients who had undergone prior transtho-
racic SAT reconstructions (4%).
Forty-five patients with symptoms of verte-
brobasilar ischemia were found radiographically to
have subclavian-vertebral artery steal. An additional
21 patients without vertebrobasilar symptoms were
found to have radiographically evident retrograde
vertebral blood flow. No patients underwent an
operation for the mere presence of subclavian steal
on an arteriogram.
Reconstructions. In the past 16 years, our
patients have been allocated to either transthoracic
or cervical reconstruction of SAT disease on the
basis of cardiopulmonary risk and the anatomic dis-
tribution of the atherosclerotic lesions. Our policy
has been for patients with multiple SAT involvement
or an innominate artery occlusion via an aortic-
based reconstruction through a median sternotomy
to undergo revascularization, provided that they
have acceptable cardiac risk. Patients with single
trunk disease and an adequate donor vessel general-
ly undergo treatment with a cervical reconstruction
and are spared the morbidity of a sternotomy. Our
policy for revascularization also has been to recon-
struct any diseased trunk that was presumed to be
causing symptoms and to reconstruct the innomi-
nate artery or branches if they were severely dis-
eased. Because little data exist regarding the natural
history of these lesions, we generally have treated
them in a manner similar to that for carotid bifurca-
tion lesions. Synchronous severe lesions of the
carotid bifurcation generally were corrected as part
of the operation if they were ipsilateral to the
patient’s SAT reconstruction; they were always cor-
rected if they were potentially related to the patient’s
symptoms. Contralateral severe carotid bifurcation
lesions were corrected at a later time.
The brain was the primary target for revascular-
ization in 155 cases (85%) in this series, as compared
with our series of transthoracic SAT reconstructions1
in which the brain was the target for revasculariza-
tion in all 100 cases. The anterior circulation was the
principal target in 114 cases, and the posterior cir-
culation, via the vertebral arteries, was the target in
41 cases. A reconstruction was performed to revas-
cularize an upper extremity in 22 cases. In an addi-
tional five cases, the goal of the revascularization was
reperfusion of myocardium via a pre-existing LIMA
graft.
All the reconstructions were performed through
cervical incisions. When anatomically possible,
efforts were made to perform arterial translocations
to avoid the use of bypass graft material. When
patient anatomy mandated the use of a bypass graft,
expanded polytetrafluoroethylene was the material
that was used most frequently. Of the 122 bypass
grafts that were completed, 94 used expanded poly-
tetrafluoroethylene as a conduit, 9 were completed
with Dacron grafts, and 17 were performed with an
autogenous greater saphenous vein. In one case in
which infected graft material was removed, a seg-
ment of superficial femoral artery was chosen.
Superficial femoral artery also was used to construct
a left carotid–subclavian bypass graft to relieve the
hemodynamic effects of a twice recurrent aortic
coarctation in a 13-year old patient.
There were 20 carotid-to-subclavian bypass
grafts, one of which was performed as a cross-neck
bypass graft via a retropharyngeal tunnel. There
were the following 72 subclavian-to-carotid bypass
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Table II. Preoperative comorbidity
No. of patients
Previous myocardial infarction 76 (42%) }70%Coronary disease 82 (45%)Congestive heart failure 56 (31%)
Hypertension 100 (55%)
Remote stroke 33 (18%)
Diabetes 27 (15%)
Prior mediastinal radiation 13 (7%)
Tobacco use 127 (70%)
Table III. Previous operations
Previous operations No. of patients
Cervical reconstruction of SAT 8
Thoracic reconstruction of SAT 9
Carotid endarterectomy 8
Vertebral reconstruction 44
Extracranial/intracranial bypass grafting 1
Aortic coarctation repair 3
Coronary bypass grafting 31
Heart valve replacement 4
Total 108
SAT, Supra-aortic trunk.
grafts: 13 were performed from a contralateral donor
subclavian; 12 were tunneled via the retropharyngeal
route; and one, early in the series, was placed in a 
pretracheal position. There were seven carotid-
to-carotid and four subclavian-to-subclavian bypass
grafts. Two of the latter bypass grafts were placed
retropharyngeally, and two were pretracheal. The dis-
tal innominate and right common carotid arteries
were replaced in 18 cases. A single retropharyngeal
innominate to left common carotid bypass grafting
procedure was performed. The subclavian artery was
transposed to the ipsilateral common carotid artery
in 45 patients, including a 23-day-old child whose
left subclavian artery had been sacrificed to repair an
aortic coarctation. The common carotid artery was
transposed onto an ipsilateral donor subclavian artery
in 14 cases and to a contralateral common carotid
artery in one case.
Secondary graft limbs were used in three cases. A
graft limb was sewn onto the side of a primary
carotid replacement graft to revascularize an ipsilat-
eral axillary artery in one case, an ipsilateral subcla-
vian in one case, and a contralateral subclavian in
one case.
Seventy-two of the 182 cervical SAT repairs
had concomitant procedures. There were 63 con-
comitant carotid bifurcation endarterectomies—
51 standard and 12 with eversion technique.3 Five
patients underwent concomitant reconstruction of
a single vertebral artery, one of which was a distal
VA reconstruction. Four patients had simultane-
ous first rib resections.
RESULTS
There were no intraoperative complications
recorded. Operative blood loss averaged 380 mL.
Only a few patients required blood transfusion.
The combined stroke/death rate was 4%. There
was a single perioperative death (0.5%) in a patient
whose operation was complicated by stroke. This
single death followed a complex cervical reconstruc-
tion that was performed to revascularize a critically
ischemic forelimb in a patient with concomitant
common carotid disease. The patient underwent
retropharyngeal bypass grafting from the left com-
mon carotid artery to the right subclavian artery and
then had the right common carotid artery reim-
planted into the side of this cross-over bypass graft.
The reconstruction failed, and the patient had a
massive right-sided cerebral hemispheric infarct. An
emergent attempt was made to reopen the recon-
struction. At reoperation, platelet aggregates were
found occluding all the grafts.
Seven nonfatal perioperative strokes occurred.
Four of the seven strokes could be attributed to peri-
operative graft occlusion. Two graft occlusion/strokes
followed retropharyngeal bypass grafting to the
carotid artery, and one of these reconstructions had
a side limb attached. A third graft occlusion/stroke
followed a left common carotid replacement in
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Fig 1. Cervical supra-aortic trunk primary patency rates.
which a side limb was also attached to perfuse the
ipsilateral subclavian artery. One stroke followed
anastomotic bleeding in a patient who underwent
retropharyngeal bypass grafting with a branch to a
dominant, single vertebral that was initially
stenosed. This patient was resuscitated and returned
to the operating room to repair the tear in the donor
contralateral subclavian artery. He had a global
ischemic event from which he recovered without
deficits in 10 days. Five of the seven strokes occurred
in the distribution of the anterior circulation, and
two occurred in the posterior circulation.
There were, in addition, two hypertensive
seizures, one transient ischemic attack, and one
episode of amaurosis fugax that occurred during the
early postoperative period. These patients all recov-
ered without permanent sequelae.
Four reconstructions (2%), including two right
subclavian-to-right carotid bypass grafts, one
retropharyngeal subclavian-to-carotid bypass graft,
and one complex bypass graft with side limbs
attached, occluded during the 30-day postoperative
period without causing any symptoms. Two of these
patients were returned to the operating room for
successful revision. Early patency of these recon-
structions was documented with physical examina-
tion, with ultrasound scan evaluation, and occasion-
ally with arteriography.
Prosthetic graft infections developed in two
patients within 30 days of the operation. The grafts,
both placed in a common carotid artery, were
explanted. In one case, the donor subclavian artery
was patched only, and the patient recovered. In the
second case, an autogenous saphenous vein bypass
graft was routed through clean tissue planes.
Six patients with pre-existing cardiac disease had
perioperative myocardial infarctions or had an exac-
erbation of congestive heart failure. Two patients
had nonfatal pulmonary emboli, significant pleural
effusions developed in six patients and necessitated
thoracentesis, and two patients required treatment
for perioperative pneumonia.
Significant wound hematomas developed in four
additional patients who were returned to the operat-
ing room for sterile evacuation. Superficial wound
infections developed in two patients and were treat-
ed with antibiotics. Five patients had transient
Horner’s syndrome. Four patients sustained injury
to the ipsilateral recurrent laryngeal nerve. All but
one of these complications followed reoperations on
the side of the subsequent nerve palsy. A reflex sym-
pathetic dystrophy developed in one patient and
necessitated several nerve blocks for relief.
The overall perioperative morbidity rate was
26%. Only a minority of these postoperative compli-
cations were classified as major morbidity. Twelve
non-neurologic complications (7%) occurred in the
asymptomatic group of patients.
The average duration of hospital stay was 5.6
days. Patients remained in an intensive care setting
after surgery for an average of 1.5 days.
Follow-up periods ranged from 1 to 190 months
(mean, 53 ± 5 months). Despite exhaustive attempts
to contact all the patients, 19 patients (10%) were
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Fig 2. Cervical supra-aortic trunk cumulative survival rates.
lost to follow-up. Sixty-two patients (34%) were
available for follow-up after 5 years, and 15 patients
(8%) were contacted after 10 years. The patients
were tracked with outpatient visits, phone calls, or
the Internet. Subsequent follow-up patency data
were acquired through physical examination, con-
tinuous Doppler scan evaluation of the carotid
artery and subclavian artery circulation, direct
duplex ultrasound scan evaluation of the reconstruc-
tion, or arteriogram. The causes for the late deaths
were extracted from state registries.
Fifty-seven late deaths occurred between 8
months and 11 years after the index revasculariza-
tion. Six late deaths occurred as the result of a
stroke. The remaining deaths were related to cardiac
complications (n = 35), pulmonary complications (n
= 3), cancer (n = 8), renal failure (n = 1), or an
unknown cause (n = 4).
A single graft failed at 4 months and was not
revised. Five additional bypass graft reconstructions
necessitated a single late revision at 3 months, 4
months, 1 year (n = 2), and 3 years. Two recon-
structions developed restenosis and were revised
twice at 2 and 8 months and at 9 and 12 years. 
All the arterial transpositions remained patent.
However, the progression of proximal donor vessel
disease did necessitate balloon angioplasty in one
case after 5 years. One pretrachial bypass graft neces-
sitated translocation to a different site in the neck to
perform a necessary tracheostomy.
Late cerebrovascular operations during the fol-
low-up period included 19 ipsilateral or contralateral
carotid bifurcation endarterectomies, nine second
SAT reconstructions (revision, angioplasty, or second
site), one vertebral reconstruction, and one extracra-
nial to intracranial bypass graft. Seven patients under-
went subsequent coronary bypass grafting.
The cumulative primary patency rates at 5 and
10 years were 91% ± 2% and 82% ± 5%, respectively.
The survival rate at 5 years was 72% ± 4% and at 10
years was 41% ± 6%. The probability of remaining
stroke free at 5 and 10 years was 92% ± 2% and 84%
± 2%, respectively. Patency and survival rate curves
(Figs 1 to 3) were plotted in accordance with the 
criteria established by the Society for Vascular
Surgery/International Society for Cardiovascular
Surgery.4,5
The surgical series also was broken down into
two subgroups for further analysis. A more complex
group of patients who had strong contraindications
to transthoracic repair or who harbored significant
disease in the innominate artery or in more than a
single SAT were compared with a second group who
underwent cervical repair of a single diseased trunk.
The complex subset was comprised of 79 patients
(43%) with extensive extracranial disease in whom
the reconstruction was performed through the neck
because previous median sternotomy, severe chronic
pulmonary or unreconstructable coronary artery
disease, or previous mediastinal radiation made
transthoracic approach exceedingly risky. The
patients were considered to be complex when the
innominate artery or more than one trunk was sig-
nificantly involved with disease. The second,
straightforward subset of 103 patients (57%) were
seen with single lesions of the carotid or subclavian
arteries and were choice candidates for a limited cer-
vical operation.
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Fig 3. Cervical supra-aortic trunk: probability of remaining stroke-free.
The long-term patient survival rates were similar
between these two subgroups, with 5-year and 10-
year survival rates for the 103 patients who were less
complex at 71% and 46%, respectively, and the 5-
year and 10-year survival rates for the 79 patients
who were at high risk/multiple vessel at 76% and
39%. Only one peri-operative stroke (1%) occurred
among the subset of patients with a single carotid or
subclavian lesion. The complex subset of patients
had seven perioperative strokes (9%). The difference
in the perioperative stroke rates between these two
groups was statistically significant (P = .01). The
only death occurred in the complex subset of
patients.
DISCUSSION
In this series, the clinical presentation, including
patient comorbidity, was similar to that of a syn-
chronous series of 100 patients who underwent
transthoracic reconstruction of the SAT.1 The distri-
bution of the arterial disease, however, differed
between the two surgical series. In the previously
reported series of transthoracic reconstructions, 98%
of the patients underwent treatment for primary ath-
erosclerotic lesions, 28% had a single innominate
artery that was treated, and 63% had multiple trunk
involvement. In this series of cervical repairs, only
3% of the patients had a single diseased innominate
artery that was reconstructed and only 24% of the
patients had multiple vessel atherosclerotic disease.
A single vessel was reconstructed in 83% of the
patients. Furthermore, 15% of the patients from this
series had the following lesions that were not pri-
marily atherosclerotic in nature: arteritis, dissection,
restenosis, aortic coarctation, graft infection, and
aneurysm.
This series has two subsets of patients. There was
a subset of 79 patients (43%) with complex or exten-
sive extracranial disease in whom the reconstruction
was performed through the neck because of a variety
of relative contraindications to a transthoracic
approach. A second subset of 103 patients (57%)
was seen with a single lesion of the carotid or sub-
clavian artery, and the patients were choice candi-
dates for a straightfoward, limited cervical operation.
Surprisingly, the more complex subgroup of patients
faired just as well as the more straightforward 
subgroup in long-term survival rates. The more
complex group did, however, experience a signifi-
cantly greater perioperative stroke/death rate. The
increased stroke/death rate may be a result of the
advanced comorbidity in this group. The use of sub-
optimal inflow sources and the fact that this group
had extensive extracranial disease probably con-
tributed to the increased mortality rates.
The substantial morbidity rate experienced by the
complex subset of patients who were symptomatic
(9%) places these patients in a higher risk category
than the general group of patients who underwent
transthoracic reconstruction (6%) and calls into ques-
tion the advantages of cervical operation in this sub-
set. However, most of these patients, by definition,
were allocated to the cervical reconstruction group
because of absolute or relative contraindications to a
transthoracic approach. It is likely that their morbid-
ity rate would have been even higher if the recon-
struction was performed through the chest.
No patient in this series underwent a concomi-
tant cardiac operation. This varies with the series of
patients who had transthoracic repair in which 7% of
the patients underwent concomitant coronary
bypass grafting or valve reconstruction at the cost of
a high mortality rate.
We prefer prosthetic material more than vein
grafts for bypass grafting when an arterial transposi-
tion is not possible. This has been our first choice
since prosthetics were first advocated in this location
by Moore et al6 and Ziomek et al.7
The retropharyngeal route was chosen for most
cross-neck reconstructions. This route permits
revascularization across the midline with a shorter
graft and does not interfere with an ulterior ster-
notomy or tracheostomy.8 One of the patients in this
series had undergone innominate to left carotid
bifurcation bypass grafting in 1984, before we start-
ed using the retropharyngeal route. In 1998, he
required a tracheostomy for chronic respiratory
management. The tracheostomy had to be preceded
by a translocation of the old functioning bypass graft
to a suprahyoid location with a sternothyroid muscle
sling.
Our surgical protocol calls for the preservation of
the LIMA, which is the best conduit for a future
coronary revascularization, when performing a trans-
position of the subclavian to the common carotid
artery. Three patients in this series underwent subse-
quent coronary revascularization with a LIMA that
had earlier been reperfused by a subclavian-to-
carotid transposition. Conversely, we encountered
five patients who had undergone LIMA revascular-
ization of the myocardium and who had recurrent
myocardial ischemia because of stenosis or occlusion
of the patent proximal left subclavian artery.
Revascularization of the left subclavian artery in
these patients must be done through a bypass graft
to avoid the interruption of flow through the patent
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LIMA graft. Patients who undergo coronary revas-
cularization should have a routine preoperative eval-
uation of their subclavian arteries with measuring
and recording arterial waveforms in both brachial
arteries, with duplex scan interrogation, or with a
left subclavian artery injection during coronary
angiography.
Cervical reconstructions of the SATs display
excellent long-term patency rates. Transpositions
exhibited a 100% patency rate in the follow-up peri-
od. The entire group of cervical reconstructions had
a 10-year primary patency rate of 82%, which com-
pares with the 88% primary patency rate for
transthoracic reconstruction.
These cervical reconstuctions can be carried out
safely—they result in minimal patient morbidity
rates even in a high-risk population. Hospital stays
are relatively short. In fact, now, most patients are
rarely admitted to an intensive care unit after
surgery, and most are discharged from the hospital
on the first postoperative day.
The survival of these patients with extracranial
arterial disease is remarkably similar for patients who
undergo operations at any anatomic site. Hertzer and
Arison9 have shown that 42% of the patients who
undergo carotid endarterectomy are dead after 10
years. A similar statistic was found in our series of
transthoracic SAT repair (52%) and in our series of
distal vertebral reconstructions (48%).1,10 In this
series of cervical repair of SAT, the survival rate at 10
years was 41%. Most of the attrition was as a result of
cardiac disease, as it was in the aforementioned series.
The cervical reconstruction of the SAT carries
acceptable death/stroke rates and provides good
long-term protection from stroke. Transposition
procedures between the subclavian and carotid
arteries have minimal morbidity and impeccable
long-term patency rates. The use of endovascular
techniques in this location can only be justified if
their performance matches the results obtained with
surgical reconstruction.
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DISCUSSION
Dr Benjamin B. Chang (Albany, NY). I would like to
congratulate Dr Berguer and his associates on his exten-
sive experience with reconstruction of the supra-aortic
trunks. His experience with arteries in the region of the
head and neck is almost unparalleled, and because of this,
we have much to learn from him in regards to the man-
agement of these cases. The current report and the fact
that he has reported previously on his experience with the
transthoracic approach for the management of supra-aor-
tic trunk disease allows him to compare and contrast the
results of these two groups in regards to morbidity and
mortality rates, unlike most of us. I would wonder
whether he could comment as to whether he thinks that at
this time there is any real advantage in terms of patency or
otherwise with a transthoracic approach or whether the
cervical approach functions just as well in this manner.
If the results with cervical-based reconstructions are
this good, would it not make sense to extend the indica-
tions possibly so that a cervical approach could be used as
long as there is one patent supra-aortic trunk to serve as a
donor vessel? Even if there was some penalty in terms of
long-term patency, do you think that a primary cervical
approach would then compromise the ability of one to fol-
low this up with a secondary transthoracic approach?
Some patients with comprise of the supra-aortic
trunks may have an orifice stenosis of, say, the left proxi-
mal subclavian artery. Would you consider the possible use
of angioplasty or stenting of such a proximal lesion to use
the subclavian artery further distally as a donor vessel for,
say, a subclavian carotid bypass graft or transposition?
Many groups, including ours, agree with your prefer-
ence for prosthetics in these types of reconstructions. I
wonder if you could comment on the 17 patients who
underwent reconstruction with autogenous vein and as to
whether there are any guidelines, outside of infection, that
would lead you to use autogenous vein at this time or if its
use is primarily historical in this series.
I also wonder if you could comment on the breadth of
your experience with endovascular procedures as you men-
tion in your manuscript. You appear to be somewhat dismis-
sive of these procedures at this point, and I do agree that
their use must be tempered in view of the excellent results
seen with conventional surgical approaches to this problem.
Nevertheless, the overall complication rate in this series was
approximately 26% major and minor, and I wonder if even-
tually some endovascular procedures might provide for ade-
quate treatment of these problems without the added surgi-
cal morbidity that you and others have seen in these patients.
Finally, a subset of your patients was treated for
asymptomatic subclavian steal. Do you regard the angio-
graphic appearance of asymptomatic steal as a primary
indication for operation, or should treatment only be
reserved for those cases in which another procedure is
being done in the same neighborhood?
I thank the Society for the privilege of discussing this
paper, and I thank Dr Berguer for teaching us so much
about the management of these patients.
Dr Ramon Berguer. Thank you, Dr Chang, for your
comments. No, I do not think the cervical approach can
be used for all patients. Patients with symptomatic lesions
of the innominate artery often do not have an anatomic
situation that lends itself to a cervical ipsilateral or con-
tralateral bypass graft. For the innominate artery lesions
specifically, if you can do a transthoracic operation, you are
better off. This applies particularly to those who have
embolizing disease as opposed to occlusive disease because
you must exclude the embolizing source in addition to
revascularizing the distal innominate artery.
As to whether I would do endovascular treatment of
the lesions in the first portion of the subclavian, the
patient who I mentioned who had a massive brain stem
stroke was specifically an indication for endovascular treat-
ment before another operation. We did an endovascular
angioplasty of the proximal subclavian artery, and the
patient had a severe brain stem stroke. I do not think I
would do that again.
You ask why there are some autogenous veins in this
series. Some of the reasons are historical—veins were used
sometimes at the beginning of this series. The other rea-
son is that we have a democratic service and some of my
partners do not share the preference I have for prosthetic
grafts.
The subclavian steal patients who were operated who
had no symptoms were patients with another significant
lesion in innominate or in the contralateral carotid. I cor-
rected the subclavian steal as a prophylactic operation to
improve collateral perfusion in preparation for the second
operation.
Dr Reginald S. A. Lord (Sydney, Australia). Dr
Berguer, we agree with your general conclusions. We have
carried out nearly 100 of these revascularizations, includ-
ing 68 that we reported previously. There are two differ-
ences between our approach and yours. First, when the
innominate artery is severely stenosed, we find that those
lesions tend to progress after cervical bypass grafting.
Those patients we prefer to deal with directly. The second
category would be the patients who also have coronary
artery disease. If they are candidates for coronary revascu-
larization, we prefer to do the cervical bypass grafting at
the same time, simultaneous with the coronary bypass
grafting.
Dr Berguer. Dr Lord, no patient in this series had a
coronary bypass graft at the time of the cervical recon-
struction. There were 8 patients in our series of transtho-
racic reconstructions who had a simultaneous coronary or
valve repair. We experienced an appalling mortality and
morbidity rate in that specific subset of patients. So, I now
am not in favor of doing the coronary reconstruction at
the same time we do the transthoracic repair. 
Dr Hazim J. Safi (Houston, Tex). I enjoyed your paper
and congratulations on your excellent results. My question
is: in your preoperative evaluation, would you include
transesophageal echocardiography to evaluate the pres-
ence or absence of atherosclerotic ascending and trans-
verse aorta?
Dr Berguer. Since I read your work on the calcific
pathology of the aortic arch, we are now screening for it
before indicating an aortic-based reconstruction in our
patients.
Dr Alan Y. Synn (Denver, Colo). Dr Berguer, thank
you for the presentation of this information. I note from
your abstract that of the 92 patients with primary common
carotid artery atherosclerotic lesions that necessitated
operation, 33 were asymptomatic. Would you share with
us your selection criteria for the asymptomatic common
carotid artery stenosis? In addition, because you are able
to accomplish cervical reconstructions with minimal mor-
bidity and mortality rates, would you describe for us your
preoperative evaluation and preparation of such patients
with regard to their medical comorbidities?
Dr Berguer. Perhaps I did not understand. You are ask-
ing me what were the indications in the 33 patients who
had common carotid lesions? 
Dr Synn. I am interested in knowing your selection cri-
teria for the 33 patients with asymptomatic common
carotid artery stenosis.
Dr Berguer. In the patients who are asymptomatic? The
mere presence of the lesion. The indication is no different
than the ones we use for internal carotid disease. We are
operating critically diseased internal carotid arteries and
do the same thing for lesions of the common carotid
artery. 
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Dr Synn. In your preoperative evaluation of these
patients, do you perform any routine cardiac screening,
such as thallium scanning or stress echo?
Dr Berguer. Not in a patient who is going to have a
simple, plain carotid subclavian transposition unless there
is some specific indication from a cardiopulmonary point
of view. It is basically a superficial operation and you do
not need all this instrumentation.
Dr Thomas S. Riles (New York, NY). The issue is that
these are patients who were asymptomatic. I understand
your rationale for wanting to fix lesions in the common
carotid arteries. In this series, however, the stroke and
death rate was 4.2%. This changes the equation a bit. So,
the question that we are raising is: is there a limit to the
complexity of reconstruction in someone who is asympto-
matic if the morbidity and mortality rate is higher than it
would be for your routine carotid operations?
Dr Berguer. Yes, I fully agree with that. If it were true,
among the subset of patients who have common carotid
disease in whom we fix asymptomatic lesions, that their
mortality and morbidity rate was the same as reported for
the total group applied to the subgroup, we should not do
them. But that is not the case. Among the patients who
had the seven strokes, three of them had complex opera-
tions with more than one graft. There were no strokes or
deaths in the asymptomatic carotid group.
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